COL7A1 and recessive dystrophic epidermolysis bullosa: Moreover, in a Col7a1–/– mouse model of RDEB, systemic administration of ABCB5+ MSCs reduced RDEB pathology and markedly prolonged the animals’ lifespans via significant reduction of skin infiltration of proinflammatory M1 macrophages (44).